Collaborative Drug Discovery Competitors and Similar CompaniesClear all

Collaborative Drug Discovery's competitors and similar companies include Ardelyx, WELLFULLY, PlanMyMedicalTrip and Asence Pharma.

	Collaborative Drug Discovery Collaborative Drug Discovery (CDD) is a company that develops scientific data management and electronic laboratory notebook (ELN) software.	Ardelyx Ardelyx develops novel oral therapeutics to treat mineral metabolism and metabolic disorders.	WELLFULLY WELLFULLY is a company that provides product performance enhancement solutions.	PlanMyMedicalTrip PlanMyMedicalTrip (PMMT) is a medical tourism company.	Asence Pharma Asence Pharma is a supplier of pharmaceutical ingredients.
Founding Date	Founding Date 2004	Founding Date 2007	Founding Date 2004	Founding Date 2015	Founding Date N/A
Type	Type Private	Type Public	Type Public	Type Private	Type Subsidiary
Tags	Tags Technology artificial intelligence data automation data management enterprise software healthtech platform	Tags Healthcare drug development healthtech	Tags Healthcare drug development healthtech	Tags Healthcare discovery platform healthtech	Tags Healthcare drug development healthtech
Locations	Locations Burlingame, US HQ Cambridge, GB Washington, US	Locations Fremont, US HQ Waltham, US Waltham, US	Locations Leederville, AU HQ	Locations Pune, IN HQ	Locations Vadodara, IN HQ Ahmedabad, IN Mumbai, IN Vadodara, IN New York, US
Employees	Employees 962% increase	Employees 882% increase	Employees 20	Employees 13	Employees 832% decrease
Valuation ($)	Valuation ($) N/A	Valuation ($) 1.4 b	Valuation ($) 1 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $407.3m (FY, 2025)	Revenue (est.) $1.5m (FY, 2023)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $39.5m (FY, 2025)	Cost of goods $1.7m (FY, 2023)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $367.8m (FY, 2025)	Gross profit ($143k) (FY, 2023)	Gross profit N/A	Gross profit N/A
Net income	Net income N/A	Net income ($61.6m) (FY, 2025)	Net income ($6.4m) (FY, 2023)	Net income N/A	Net income N/A